Topical 0.3% Ciprofloxacin vs Topical 0.3% Ofloxacin in Early Treatment of Pseudomonas aeruginosa Keratitis in a Rabbit Model

By LaBorwit Scott E.   Katz Harold R.   Hirschbein Marc J.   Oswald Michael R.   Snyder Lori S.   Schwartz Ken S.   Herling Irvin E.  

Annals of Ophthalmology, Vol. 33, Iss. 1, 2001-03 ,pp. : 48-52

Humana Press, Inc

Access to resources Recommend Favorite

Type III Secretion System–Associated Toxins, Proteases, Serotypes, and Antibiotic Resistance of Pseudomonas aeruginosa Isolates Associated with Keratitis

By Zhu Hua   Conibear Tim   Bandara Rani   Aliwarga Yulina   Stapleton Fiona   Willcox Mark  

Current Eye Research, Vol. 31, Iss. 4, 2006-05 ,pp. : 297-306

Informa Healthcare

Access to resources Recommend Favorite

Nona-D-Arginine Amide for Prophylaxis and Treatment of Experimental Pseudomonas aeruginosa Keratitis

By Karicherla Priyanka   Hobden Jeffery A.  

Current Eye Research, Vol. 35, Iss. 3, 2010-03 ,pp. : 220-224

Informa Healthcare

Access to resources Recommend Favorite

Emerging Moxifloxacin Resistance in Pseudomonas aeruginosa Keratitis Isolates in South India

By Oldenburg Catherine E.   Lalitha Prajna   Srinivasan Muthiah   Rajaraman Revathi   Ravindran Meenakshi   Mascarenhas Jeena   Borkar Durga S.   Ray Kathryn J.   Zegans Michael E.   McLeod Stephen D.   Porco Travis C.   Lietman Thomas M.   Acharya Nisha R.  

Ophthalmic Epidemiology, Vol. 20, Iss. 3, 2013-06 ,pp. : 155-158

Informa Healthcare

Access to resources Recommend Favorite

Corneal response to Pseudomonas aeruginosa infection

By Hazlett L.D.  

Progress in Retinal and Eye Research, Vol. 23, Iss. 1, 2004-01 ,pp. : 1-30

Elsevier

Access to resources Recommend Favorite